How Waldenstrom Macroglobulinemia Medications Work

The primary goal of medications in treating Waldenstrom Macroglobulinemia (WM) is to reduce the production of abnormal proteins, alleviate symptoms, and manage complications. WM is a type of non-Hodgkin lymphoma characterized by the overproduction of IgM antibodies.

Gold Standard Treatment: Bendamustine

Bendamustine, a chemotherapy agent, is considered the gold standard treatment for WM. It works by:

• Interfering with DNA replication and cell division, leading to cell death
• Inducing apoptosis (programmed cell death) in malignant B cells
• Reducing IgM production and alleviating hyperviscosity syndrome symptoms

Alternative Treatments

Other treatment options for WM include:

• Rituximab: a monoclonal antibody that targets CD20-positive B cells, reducing IgM production and alleviating symptoms
• Fludarabine: a chemotherapy agent that interferes with DNA replication and cell division, leading to cell death
• : an immunomodulator that stimulates the immune system to attack malignant B cells

These alternative treatments may be used as first-line therapy or in combination with bendamustine for patients who are not suitable for standard treatment or have relapsed disease.